Covigilant Research, LLC Clinical Trials Site Management Organization

Covigilant Research, LLC

Committed To Working Together

Belimumab after rituximab reduces IgG anti-dsDNA antibody levels, flare risk in lupus – Healio,

… for treatment of lupus following two large phase 3 clinical trials (BLISS 52 … by the National Institute for Health and Clinical Excellence, …, … for treatment of lupus following two large phase 3 clinical trials (BLISS 52 … by the National Institute for Health and Clinical Excellence, …, Read More

Scroll to Top